HIGHLIGHTS
- who: Toshihide Izumida et al. from the Second Department of Medicine, University of Toyama, Toyama, Japan have published the research: Therapeutic Strategy for Patients with Concomitant Pulmonary Artery Hypertension and Hypertrophic Obstructive Cardiomyopathy: A Rare Case Report, in the Journal: Medicina 2023, 401 of 18/02/2023
- what: We reported combined case of HOCM and Sjogren-syndrome-associated PAH.
SUMMARY
Initiation/withdrawal of anti-PAH agents affect the amount of preload on the left ventricle and might have negative/positive impacts on HOCM. The initiation of anti-PAH agents worsened her . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.